PIC/S Guide Update and Annex 16 Adoption: Navigating Australia’s Pharmaceutical Landscape
Australia is set to make a significant step in enhancing the safety and efficacy of medicinal products, active pharmaceutical ingredients (APIs), and sunscreens with a planned update to its manufacturing principles. As of 3rd June 2024, the country will transition to PIC/S Guide to GMP – 1 February 2022, PE009-16, with exclusions from Annexes 4,…